Nathalie brings a 18 year proven track record as equity fund manager. She invested a combined USD 3.7B in listed and Private Equities for several European based mutual biotech and healthcare funds. She managed biotech and life sciences funds for Clariden Bank (Credit Suisse), Global Asset Management (GAM) and for Pictet Asset Management. She also provided start-up and growth capital to more than 10 private companies by investing in ventures such as Biomarin Pharmaceuticals and several Swiss private companies. Furthermore, she managed custom made biotech and medical technology mandates for several European based family offices between 2001 and 2014.
Nathalie holds a master in biochemistry and a PhD in biochemistry and oncology from the Biozentrum, University of Basel.